Title:
【発明の名称】ヒト・バニロイド受容体およびその使用
Document Type and Number:
Japanese Patent JP2002531085
Kind Code:
A
Abstract:
The invention provides novel human vanilloid receptor (hVR) proteins, in particular hVR1 and hVR3, nucleotide sequences encoding for the novel hVR proteins, and hVR proteins for use in a method for screening for agents useful in the treatment or prophylaxis of disorders which are responsive to modulation of hVR activity in a human patient. The invention also provides expression vectors comprising said nucleotide sequences, stable cell lines comprising said expression vectors, antibodies specific for the novel hVR proteins, methods for the identification of compounds which exhibit hVR modulating activity, compounds identifiable and identified by such methods, and methods of treatment or prophylaxis of disorders which are responsive to modulation of hVR activity in a human patient.
Inventors:
Delaney, Natalie Samantha
Sansoe, Philip
Tate, Simon Nicholas
Sansoe, Philip
Tate, Simon Nicholas
Application Number:
JP2000585397A
Publication Date:
September 24, 2002
Filing Date:
November 30, 1999
Export Citation:
Assignee:
GLAXO GROUP LIMITED
International Classes:
A61K45/00; A61P1/00; A61P11/00; A61P11/06; A61P13/00; A61P19/00; A61P25/04; A61P25/06; A61P25/28; A61P29/00; C07K14/705; C07K16/28; C12N5/10; C12N15/12; C12P21/02; C12Q1/02; G01N33/50; G01N33/53; C12N15/09; G01N33/566; C12R1/91; (IPC1-7): C12N15/09; A61K45/00; A61P1/00; A61P11/00; A61P11/06; A61P13/00; A61P19/00; A61P25/04; A61P25/06; A61P25/28; A61P29/00; C07K14/705; C07K16/28; C12N5/10; C12P21/02; C12Q1/02
Attorney, Agent or Firm:
Takehiko Suzue (4 outside)